TomTurboInvest (@TomTurboInvest) sur getquin

6J·

$BNTX (-3,32 %) Jeffries has raised the price targets for BioNTech today 😀

The share price has suffered recently, but with a weekly balance of +37% and a monthly balance of +47%, it is heading in the right direction again🚀

The target price adjustment reflects the potential that BioNTech's ongoing research and development activities could have for the company's future prospects.

BioNTech's strategy is to prioritize chemotherapy combinations before exploring antibody-drug conjugate (ADC) combinations. To this end, the company has initiated global Phase 2 trials of BNT327 in combination with chemotherapy for breast cancer (BC) and small cell lung cancer (SCLC). In addition, BioNTech plans to complete a first-line study in lung cancer.

Biontech is aiming for first market approval for a cancer drug in 2026, after which annual market approvals in oncology are planned.

Current stock: 131 units

TomTurboInvest

@TomTurboInvest

3Mo·

$BNTX (-3,32 %) I increased my BioNTech position a little yesterday. Another position went into each of the two children's portfolios.

Certainly a company where you still need a little patience.

In addition to the development of coronavirus vaccines, the focus at Biontech is now on oncology research. The first cancer drug is due to be launched on the market in 2026.

By 2030, the company aims to have achieved ten approvals in various cancer indications.

29.05

BioNTech SE ADR

Acheté x15 à 85,50 €

1 282,50 €

18 Commentaires

Tim@investorsapiens

I've been in here since 2020, at times with over 400% and then back to the starting point 😅. I missed the exit back then and since then I've been keeping my fingers crossed that BioNTech manages to beat cancer. A good share price would then be almost secondary. But so far it remains more of a dream ;)

•

Voir toutes les 10 autres réponses

Dividende > Zinsen@GoDividend

Hallelujah that's a thing

•

Voir toutes les 4 autres réponses

Thommy98@Thommy98

Seems like it's going to continue like this on Monday. Great data from the ESMO on BNT327. Nice to see the position in positive territory again, it's been a really long time chewing soap.

•

Afficher la réponse

Participez à la conversation